RARX addendum—Arbs could’ve made 18.5% in two weeks if they had bought on Mar 18 (#msg-154416552). The price cratered that day, not because of anything specific to RARX, but rather from general dysfunction in the securities markets.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”